Cargando…
Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415234/ https://www.ncbi.nlm.nih.gov/pubmed/37563525 http://dx.doi.org/10.1186/s40981-023-00643-7 |
| _version_ | 1785087485787766784 |
|---|---|
| author | Araki, Hideharu Inoue, Satoki |
| author_facet | Araki, Hideharu Inoue, Satoki |
| author_sort | Araki, Hideharu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10415234 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104152342023-08-12 Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation Araki, Hideharu Inoue, Satoki JA Clin Rep Letter to the Editor Springer Berlin Heidelberg 2023-08-11 /pmc/articles/PMC10415234/ /pubmed/37563525 http://dx.doi.org/10.1186/s40981-023-00643-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Araki, Hideharu Inoue, Satoki Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation |
| title | Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation |
| title_full | Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation |
| title_fullStr | Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation |
| title_full_unstemmed | Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation |
| title_short | Switching to remimazolam followed by flumazenil may be a promising combination for deep extubation |
| title_sort | switching to remimazolam followed by flumazenil may be a promising combination for deep extubation |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415234/ https://www.ncbi.nlm.nih.gov/pubmed/37563525 http://dx.doi.org/10.1186/s40981-023-00643-7 |
| work_keys_str_mv | AT arakihideharu switchingtoremimazolamfollowedbyflumazenilmaybeapromisingcombinationfordeepextubation AT inouesatoki switchingtoremimazolamfollowedbyflumazenilmaybeapromisingcombinationfordeepextubation |